GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a major focus in therapeutic research, largely due to its impressive impact on controlling conditions such as type 2 diabetes and weight gain. Recent studies have shown that beyond glucose management, GLP-1 agonists offer potential for heart health and perhaps brain conditio